Twitter-Delivered CME/CE on
Chronic Kidney Disease from @ckd_ce
The need for consistent updates and agile content is imperative for today’s clinician to remain current on the continuum of scientific data. This is particularly important in the care of patients with or at risk for CKD, as this has become a multidisciplinary and interprofessional focus. Kidney health is now linked not only pathophysiologically but also by treatment strategies that target diverse cardiovascular outcomes as well as renal health. These issues are subject to frequent pivotal trial publications, guidelines updates, FDA action, and outcomes assessments.
Our Tweetorials
Your new source for free CE/CME via Twitter!
Each program provides 0.5hr – 1.0hr credit for physicians, pharmacists, and nurses.
Multidisciplinary Management of the Patient with T2D and CKD 3-4
2) This #accredited #tweetorial on #kidneydisease #CKD is supported by an independent educational grant from the Boehringer Ingelheim/Lilly...
Multidisciplinary Management of the patient with T2D and CKD 1-2
2) This #accredited #tweetorial series on #kidneydisease #CKD is supported by an independent educational grant from the Boehringer Ingelheim/Lilly...
The Complex Interactions Between Disordered Sleep and T2D
1) Welcome to a new #accredited #tweetorial on the intersection of #T2D & #sleep_disorders, 🔭💤importance of duration & quality of sleep as...
AHA2022 UPDATE: META-ANALYSIS INDICATES SGLT2i SHOULD BE FOUNDATIONAL THERAPY IN CKD
2) This work was presented by Will Herrington @willkidney, @The_MRC @Kidney_Research UK funded AssocProf @Oxford_NDPH and representing the...
Best Practices in the Management of CKD-Associated Anemia
2) Our author is Carlo Trinidad 🇵🇭 @hellokidneyMD, Kidney Doctor, Preventive Medicine + Patient Education specialist, Visual Abstract Editor 🎨, and...
AHA2022 UPDATE: MORE ON RENOPROTECTIVE EFFECTS OF SGLT2-I AND COLLABORATIVE META-ANALYSIS OF LARGE PLACEBO-CONTROLLED TRIALS
2a) The same weekend that Will Herrington @willkidney, @The_MRC @Kidney_Research UK @Oxford_NDPH presented #EMPA_KIDNEY results at #ASN22 (see...
ASN2022 UPDATE: EMPA-KIDNEY EMPHASIZES RENOPROTECTIVE EFFECTS OF SGLT2-i
2) This work was presented by Will Herrington @willkidney, @The_MRC @Kidney_Research UK funded AssocProf @Oxford_NDPH and representing the...
CLINICAL TRIAL RESULTS AND EMERGING DATA FOR HIF-PHI AS THERAPY FOR CKD-ASSOCIATED ANEMIA
2) This #accredited #tweetorial series on #kidneydisease #aCKD is supported by an independent educational grant from GSK plc and is intended for...
Management of Older Adults with Type 2 Diabetes & Frailty
2) Statement of accreditation and faculty disclosures can be viewed at https://t.co/PHlIpplEO4. @ckd_CE is your ONLY source for #accredited...
Strategies to Apply Current Clinical Trial Data for SGLT2i to Reduce the Progression of CKD
2) This program is #accredited for CE/#CME #physicians #physicianassociates #nurses #pharmacists #nursepractitioners & is supported by an...
@CKD_CE on Twitter
Your only source for ACCREDITED SoMe-delivered
serialized professional cardiometabolic education. Physicians, nurses, pharmacists–come one, come all!
On Twitter at @ckd_ce, we present a series of tweetorials, Twitter-delivered case studies, and Twitter Journal Clubs, each accredited for 0.5hr – 1.0hr CE/CME. Programs are presented by expert faculty in engaging and fully interactive format. Our unique program harnesses the reach, up-to-the-minute currency, and accessibility of social media to deliver a constant flow of accredited, interactive, expert-delivered educational programs to a multidisciplinary and interprofessional audience of engaged clinicians.